Proteomics

Dataset Information

0

Serum N-glycopeptidomics of oral squamous cell carcinoma patients and healthy controls: N-glycopeptidomics


ABSTRACT: The serum N-glycopeptidomics of 41 oral squamous cell carcinoma patients and 44 healthy controls were compared in this project. This project is the second part of a two-part project, where proteomics and N-glycopeptidomics were analyzed in-parallel. The quantitation of N-glycopeptides was performed with MSE in sensitivity mode and the identification with MS2 Fast DDA.

INSTRUMENT(S):

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Blood Serum

DISEASE(S): Oral Squamous Cell Carcinoma

SUBMITTER: Sakari Joenväärä  

LAB HEAD: Prof. Risto Renkonen

PROVIDER: PXD055600 | Pride | 2026-02-09

REPOSITORIES: Pride

Dataset's files

Source:
Action DRS
20200922_OSCC_SEC_GP_04.raw.zip Raw
20200922_OSCC_SEC_GP_05.raw.zip Raw
20200922_OSCC_SEC_GP_06.raw.zip Raw
20200922_OSCC_SEC_GP_07.raw.zip Raw
20200922_OSCC_SEC_GP_08.raw.zip Raw
Items per page:
1 - 5 of 304
altmetric image

Publications

Disease-specific N-glycopeptides in serum of patients with oral squamous cell carcinoma.

Tohmola Tiialotta T   Joenväärä Sakari S   Dickinson Amy A   Mäkitie Antti A   Silén Suvi S  

Scientific reports 20250902 1


The incidence of oropharyngeal cancers is increasing due to human papilloma virus (HPV); however, this phenomenon does not explain the rising incidence of oral cancers, for which the reason remains unknown. These cancers are typically diagnosed at an advanced stage, which adversely affects the prognosis. Improved methods for early detection, such as blood-based biomarkers, could significantly improve patient outcomes. We investigated quantitative and qualitative differences in serum protein N-gl  ...[more]

Similar Datasets

2026-02-09 | PXD055139 | Pride
2010-10-20 | GSE24783 | GEO
2024-08-26 | GSE240952 | GEO
2024-08-26 | GSE240951 | GEO
2020-07-07 | GSE150469 | GEO
| S-ECPF-GEOD-28100 | biostudies-other
| S-EPMC5458226 | biostudies-literature
2025-05-07 | PXD058846 | Pride
2020-01-13 | GSE134185 | GEO
2022-04-13 | MSV000089251 | MassIVE